Ironwood Pharmaceuticals, Inc. (IRWD) reported break-even earnings for the second quarter of 2024 compared with the Zacks Consensus Estimate of earnings of 17 cents per share. The company had recorded adjusted earnings of 31 cents per share in the year-ago quarter.Total revenues in the second quarter were $94.4 million, which also missed the Zacks Consensus Estimate of$104 million. The top line decreased almost 12.1% year over year due to the decrease in collaborative arrangements revenues related to the s ...